Literature DB >> 11789963

Peripheral arterial disease--epidemiological aspects.

M H Criqui1.   

Abstract

As many as 10 million people in the USA have peripheral arterial disease (PAD) with a prevalence over 10% in people aged more than 60 years old. Generally, men have a higher prevalence of PAD than women. The risk factors for PAD are similar to those for coronary artery disease (CAD) and cerebrovascular disease (CBVD), but diabetes and cigarette smoking have a particularly strong association with PAD. Patients with PAD also have CAD and CBVD as co-morbidities, although the extent of co-morbidity depends on the sensitivity of assessment. The risk of mortality is proportional to the severity of PAD, and the relative risk of all-cause mortality due to PAD is unaltered by the presence of CAD or CBVD. PAD is under-recognized and under-treated, even though it should be regarded as a severe disease leading to significant death and disability from stroke and myocardial infarction (MI). Thus, accurate diagnosis of PAD could provide an early indication of the need for intervention and help prevent future morbidity and mortality.

Entities:  

Mesh:

Year:  2001        PMID: 11789963     DOI: 10.1177/1358836X0100600i102

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  77 in total

1.  Patient selection and preparation strategies for the use of contrast material in patients with chronic kidney disease.

Authors:  Poul Erik Andersen
Journal:  World J Radiol       Date:  2012-06-28

2.  Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosis.

Authors:  Prakash Krishnan; K-Raman Purushothaman; Meerarani Purushothaman; Irene C Turnbull; Arthur Tarricone; Miguel Vasquez; Sachin Jain; Usman Baber; Rheoneil A Lascano; Annapoorna S Kini; Samin K Sharma; Pedro R Moreno
Journal:  Atherosclerosis       Date:  2016-06-30       Impact factor: 5.162

3.  High prevalence of peripheral arterial disease in patients with obstructive sleep apnoea.

Authors:  C A Schaefer; L Adam; J Weisser-Thomas; S Pingel; G Vogel; U Klarmann-Schulz; G Nickenig; C Pizarro; D Skowasch
Journal:  Clin Res Cardiol       Date:  2015-03-01       Impact factor: 5.460

4.  Long term outcomes in diabetic patients treated with atherectomy for peripheral artery disease.

Authors:  Adam J Janas; Krzysztof P Milewski; Piotr P Buszman; Wojciech Trendel; Aleksandra Kolarczyk-Haczyk; Mariusz Hochuł; Maciej Pruski; Wojciech Wojakowski; Paweł E Buszman; Radosław S Kiesz
Journal:  Cardiol J       Date:  2018-11-05       Impact factor: 2.737

5.  Pulse pressure and subclinical peripheral artery disease.

Authors:  P Korhonen; H Kautiainen; P Aarnio
Journal:  J Hum Hypertens       Date:  2013-10-17       Impact factor: 3.012

Review 6.  Clinical application of stem cells for therapeutic angiogenesis in patients with peripheral arterial disease.

Authors:  Kyung-Bok Lee; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

7.  Multi-channel electrical bioimpedance: a new noninvasive method to simultaneously measure cardiac and peripheral blood flow.

Authors:  Alfred W H Stanley; Jeffery W Herald; Constantine L Athanasuleas; Saji C Jacob; Scott W Sims; Alfred A Bartolucci; Alexander N Tsoglin
Journal:  J Clin Monit Comput       Date:  2007-10-09       Impact factor: 2.502

8.  Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease.

Authors:  Monica L Bertoia; Jennifer K Pai; John P Cooke; Michel M Joosten; Murray A Mittleman; Eric B Rimm; Kenneth J Mukamal
Journal:  Atherosclerosis       Date:  2014-04-28       Impact factor: 5.162

9.  Peripheral arterial disease: lack of awareness in Canada.

Authors:  Marge Lovell; Kenneth Harris; Thomas Forbes; Gwen Twillman; Beth Abramson; Michael H Criqui; Paul Schroeder; Emile R Mohler; Alan T Hirsch
Journal:  Can J Cardiol       Date:  2009-01       Impact factor: 5.223

Review 10.  Intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches.

Authors:  Taisei Kobayashi; Sahil A Parikh; Jay Giri
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.